The words impossible port, punching above its weight, and even black magic are thrown around often when it comes to games on diminutive hardware. With Hogwarts Legacy, now launching on the Nintendo’s ...

Danish biotech Adcendo has accelerated its progression to a clinical-stage biotech by licensing an antibody-drug conjugate (ADC) from China's Multitude Therapeutics with potential in various forms of ...

The Nintendo Switch 2 is the successor to the first generation family of Nintendo Switch consoles, including the regular Switch, Switch Lite, and Switch OLED model, but how does the Switch 2 compare?

Looking for a great game to play on your Switch or Switch 2? Check out Hades II, Mina the Hollower, Monster Hunter Rise, and the rest of our favorite Nintendo titles. I’m PCMag’s home theater and ...

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

Nintendo’s Switch 2 is approaching the end of the first year of its life — and, as with every young console, excitement for the new hardware is held in check by the quest for something to play on it.

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.